生物信息学
体外
医学
药理学
对接(动物)
细胞生长
侧柏属
血管内皮生长因子
血管内皮生长因子A
细胞培养
血管内皮生长因子受体
血管生成
生物化学
体内
毛乳头
细胞周期
阿帕蒂尼
奎宁酸
细胞
淋巴瘤
生物
作者
Yijie Du,Siqi Zhao,Yueheng Liu,Yujing Shi,Yan Jia,Changyong Luo
出处
期刊:Medicine
[Wolters Kluwer]
日期:2026-07-17
卷期号:105 (29): e49653-e49653
标识
DOI:10.1097/md.0000000000049653
摘要
To identify the active compounds of Platycladus orientalis leaf extract (POE) and quantify its efficacy against androgenetic alopecia (AGA) via vascular endothelial growth factor A (VEGFA)/B-cell lymphoma 2 (Bcl-2) signaling. Active compounds and their potential targets in POE were first identified. A compound-target interaction network was constructed using network pharmacology approaches, and molecular docking was employed to evaluate the binding affinities of key compounds to their predicted targets. Furthermore, in vitro experiments were conducted to assess the effects of key bioactive constituents on the expression levels of proteins involved in the VEGFA/Bcl2 pathway. POE promotes dermal papilla cell proliferation and angiogenesis by activating VEGFA/Bcl-2 signaling. Network pharmacology screened 28 compounds against 506 androgenetic alopecia targets; the top 6 (amentoflavone, isoquercitrin, afzelin, phloretin, pinusolide, and quinic acid) were docked to VEGFA (threshold Vina score < -7.0). POE at 3.13 µg mL-1 increased dermal papilla cell number by 15.6 ± 1.2% versus control (P < .01) and up-regulated VEGFA (0.76 ± 0.02 vs 0.64 ± 0.03), Bcl-2 (0.86 ± 0.01 vs 0.79 ± 0.01) and phosphorylated B-cell lymphoma 2 (0.81 ± 0.01 vs 0.71 ± 0.01); all P < .01. Efficacy matched 10 µg mL-1 minoxidil (P > .05).
科研通智能强力驱动
Strongly Powered by AbleSci AI